Their research group is currently evaluating their hypothesis by determining plasma dp-ucMGP and DES levels in patients with alpha-1 antitrypsin deficiency (AATD), a pulmonary disease characterized by highly accelerated elastin degradation in the lungs. The gene discussed is ELN; the disease is alpha 1-antitrypsin deficiency.